Among the report’s six predicted trends, PwC suggests the government’s emphasis on health outcomes as a basis for payments will require pharmaceutical companies to combine product offerings with data and supplemental services that add value through improved outcomes and efficiencies.
The five other trends listed in the report include new product types, incremental product launches that can alter sales curves, new modes of healthcare delivery, growing importance of emerging markets and greater public scrutiny.
Read the PwC news release about Supplying the Future: Which path will you take?
Read other coverage about pharmaceutical companies:
– Actavis to Pay $170M for Reporting False Prices to Medicaid
– St. Jude Medical to Pay $16M to Settle Kickback Allegations
– Pharmaceutical Company Will Pay $280M to Settle False Claims Allegations
